Skip to main content
. 2020 Aug 29;24(1):22–31. doi: 10.1093/ijnp/pyaa068

Figure 2.

Figure 2.

Least-square mean changes (±SE) from baseline for Montgomery-Asberg Depression Rating Scale (MADRS) total score during the double-blind treatment phase (mixed-effects model using repeated measures [MMRM]; observed cases). aIncludes patients who had their dose reduced due to tolerability issues. Note: Negative change in score indicates improvement.